Oct 29, 2021
HIV-1 Therapeutics Market is expected to grow with the entry of novel therapies and the R&D activities by key companies including GSK, Merck,
Read More...
Oct 27, 2021
The United States (US) tops the global pharmaceutical industry and accounts for 46% of total global revenue followed by China, Japan, Germany
Read More...
Oct 25, 2021
von Willebrand Disease (vWD) treatment market in the US is categorized as Replacement therapy, Adjunct therapy, and Non-replacement therapy..
Read More...
Oct 22, 2021
Globally, leading companies in the gene therapies for dermatology such as Krystal Biotech, Kastle Creek, Azitra, Abeona, Amryt, Holostem, and
Read More...
Oct 18, 2021
Gene therapy is becoming a pioneer in treating dermatology diseases and pharma companies are actively working on new gene therapies
Read More...
Oct 15, 2021
Heart failure (HF), also referred to as Congestive Heart failure (CHF), is a condition in which the heart muscle fails to pump blood as efficiently as it should. This causes an accumulation of blood and fluid in the lungs, resulting in shortness of breath. Certain heart conditions, such as narrowed arteries in the ...
Read More...
Oct 13, 2021
Hearing Loss Treatment Market is expected to grow owing to the initiative by key companies in the domain such as MED-EL, Sonova..
Read More...
Oct 08, 2021
Digital Therapeutics for Depression market is growing due to initiatives by key companies in the domain such as Happify, Otsuka, Sanvello,
Read More...
Oct 06, 2021
Nutraceuticals Market is expected to grow at a CAGR of 8.82% by 2026, owing to the initiative by key companies like Koninklijke, DuPont, BASF
Read More...
Oct 04, 2021
Myocardial Infarction Market revenue was worth $ 11,038 million in 2020 in the 7MM, which is expected to increase by 2030. Key Companies such
Read More...
Discover How Learning Disability Treatment Landscape is Evolving with the Emergence of Digital Assistant Technologies
Jul 04, 2025
A New Era for Multiple Myeloma Treatment: Bispecific Antibodies Enter the Fray
Jun 10, 2025
LEQEMBI: A New Hope for Alzheimer’s Disease Patients
Feb 12, 2025
Newsletter/Whitepaper